Inelegant Investor is a collection of real-world investing observations, focused on the edge cases that don’t show up in textbooks — restructurings, CVRs, spinoffs, and the strange outcomes that accumulate in actual portfolios. And whatever else interests me about investing. Investing isn't always pretty, it's usually quite inelegant.
Recent Series: The Portfolio Graveyard
When a company announces plans to buy back 10%, 15% or even more of its outstanding stock through a modified Dutch auction, investors should pay attention. That does not mean they should buy the stock. A large self-tender is one of the more consequential capital-allocation decisions a public company can make. Unlike an ordinary open-market repurchase authorization, which… Read More »
You have the transfer form. You have your identification. You know you need a Medallion Signature Guarantee. Then your bank tells you: “We don’t do those.” Or perhaps the bank does offer them, but not at your branch. Or only for customers who have been there for six months. Or not for securities held somewhere else. Or the… Read More »
You have some stock to transfer. The transfer agent sends you a form. You fill it out. Then you reach a line that says your signature must be accompanied by a Medallion Signature Guarantee. Fine. You know what a notary is. Surely this is the financial-services version of the same thing. It is not. You bring the document… Read More »
Every so often, a brokerage account acquires something that looks less like an investment and more like a clerical error. Instead of a company name and ticker, you may see something like: 007CVR020 550CVR021 CONTRA AEGLEA BIOTHERA or some other cryptic string ending in CVR The market value may be $0.00. There may be no quote. Clicking on… Read More »
Invest long enough and you accumulate scars. Some are remembered only when you look back at an old trade and wonder what on earth you were thinking. Others are more considerate. They remain right there in your brokerage account, where you can look at them every day. $0.00. A bankrupt company. A dead ticker. A mysterious CUSIP. Perhaps… Read More »
This article is part of a short series on the strange things that accumulate at the bottom of a brokerage account. Part 1 covered the portfolio graveyard broadly, and Part 2 focused on CVRs. This time, we are looking at the rest of the collection. Because not everything haunting a portfolio is a contingent value right. Some positions… Read More »
If you missed it, this article is part of a short series on the odd debris that collects at the bottom of a brokerage account. Part 1 looked at the portfolio graveyard generally. This time, I want to focus on one of its strangest residents: The contingent value right, or CVR. Quick Answer: A CVR (contingent value right)… Read More »
They Can Check Out Anytime They Want- But They Can Never Leave If you spend enough time investing in nanocaps, microcaps, pink sheets, and special situations, your portfolio develops something unexpected: A basement. Scroll far enough down your brokerage account and you’ll find it – a list of positions that: no longer trade no longer report and, according… Read More »
In which Pooh discovers that crypto honey is gone, an environmental acorn may yet grow, multifamily houses vanish, and the old biotech jars are to be offered for sale. Hundred Acre Nasdaq, August 2025 — Windtree the Pooh (NASDAQ: WINT), a Bear of Very Little Capital but Very Big Announcements, today reported that its crypto treasury adventure… Read More »
In which Windtree(WINT) remembers it is a drug company after all, and says something Clinical before lunch A whimsical tale of finance and pharmaceuticals, as told in the Hundred Acre Nasdaq. One day in the Hundred Acre Nasdaq, Windtree the Pooh awoke to a rather curious thing: A press release. It was early, and quite serious. And… Read More »